These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 6312967)
1. The metabolism in vitro of human low-density lipoprotein by the human hepatoma cell line Hep G2. Havekes L; van Hinsbergh V; Kempen HJ; Emeis J Biochem J; 1983 Sep; 214(3):951-8. PubMed ID: 6312967 [TBL] [Abstract][Full Text] [Related]
2. Regulation of low-density lipoprotein receptors in the human hepatoma cell line Hep G2. Illingworth DD; Lindsey S; Hagemenas FC Exp Cell Res; 1984 Dec; 155(2):518-26. PubMed ID: 6094224 [TBL] [Abstract][Full Text] [Related]
3. Complete down-regulation of low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2 by beta-migrating very-low-density lipoprotein and non-lipoprotein cholesterol. Different cellular regulatory pools of cholesterol. Kamps JA; van Berkel TJ Eur J Biochem; 1992 Jun; 206(3):973-8. PubMed ID: 1318843 [TBL] [Abstract][Full Text] [Related]
4. Estrogens induce low-density lipoprotein receptor activity and decrease intracellular cholesterol in human hepatoma cell line Hep G2. Semenkovich CF; Ostlund RE Biochemistry; 1987 Aug; 26(16):4987-92. PubMed ID: 2822102 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of LDL receptor activity in Hep-G2 cells by a serum factor(s). Ellsworth JL; Brown C; Cooper AD J Cell Physiol; 1988 May; 135(2):213-23. PubMed ID: 2836440 [TBL] [Abstract][Full Text] [Related]
6. Regulation of low-density-lipoprotein receptors in the human hepatoma cell line Hep G2. Effect of phorbol 12-myristate 13-acetate and low-density lipoprotein. Kamps JA; van Berkel TJ Eur J Biochem; 1993 May; 213(3):989-94. PubMed ID: 8389299 [TBL] [Abstract][Full Text] [Related]
7. Activity and regulation of low density lipoprotein receptors in a human hepatoblastoma cell line. Wu GY; Wu CH; Rifici VA; Stockert RJ Hepatology; 1984; 4(6):1190-4. PubMed ID: 6094330 [TBL] [Abstract][Full Text] [Related]
8. Calcium antagonists and low density lipoproteins metabolism by human fibroblasts and by human hepatoma cell line HEP G2. Corsini A; Granata A; Fumagalli R; Paoletti R Pharmacol Res Commun; 1986 Jan; 18(1):1-16. PubMed ID: 3006091 [TBL] [Abstract][Full Text] [Related]
9. Regulation of low density lipoprotein receptor function in a human hepatoma cell line. Leichtner AM; Krieger M; Schwartz AL Hepatology; 1984; 4(5):897-901. PubMed ID: 6090292 [TBL] [Abstract][Full Text] [Related]
10. Lipoprotein metabolism by rat hepatomas. Studies on the etiology of defective dietary feedback inhibition of cholesterol synthesis. Barnard GF; Erickson SK; Cooper AD J Clin Invest; 1984 Jul; 74(1):173-84. PubMed ID: 6330173 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the low-density-lipoprotein-receptor-independent interaction of beta-very-low-density lipoprotein with rat and human parenchymal liver cells in vitro. De Water R; Kamps JA; Van Dijk MC; Hessels EA; Kuiper J; Kruijt JK; Van Berkel TJ Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):41-8. PubMed ID: 1311560 [TBL] [Abstract][Full Text] [Related]
12. Stimulation of the LDL receptor activity in the human hepatoma cell line Hep G2 by high-density serum fractions. Havekes LM; Schouten D; de Wit EC; Cohen LH; Griffioen M; van Hinsbergh VW; Princen HM Biochim Biophys Acta; 1986 Feb; 875(2):236-46. PubMed ID: 3002482 [TBL] [Abstract][Full Text] [Related]
13. Endotoxins inhibit endocytotic catabolism of low-density lipoproteins in Hep G2 cells. Liao W; Florén CH Hepatology; 1992 Jul; 16(1):224-31. PubMed ID: 1319951 [TBL] [Abstract][Full Text] [Related]
14. Kinetics of low-density lipoprotein receptor activity in Hep-G2 cells: derivation and validation of a Briggs-Haldane-based kinetic model for evaluating receptor-mediated endocytotic processes in which receptors recycle. Harwood HJ; Pellarin LD Biochem J; 1997 May; 323 ( Pt 3)(Pt 3):649-59. PubMed ID: 9169597 [TBL] [Abstract][Full Text] [Related]
15. Evidence for sterol-independent regulation of low-density lipoprotein receptor activity in Hep-G2 cells. Ellsworth JL; Chandrasekaran C; Cooper AD Biochem J; 1991 Oct; 279 ( Pt 1)(Pt 1):175-87. PubMed ID: 1930137 [TBL] [Abstract][Full Text] [Related]
17. Effects of compactin, mevalonate and low-density lipoprotein on 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and low-density-lipoprotein-receptor activity in the human hepatoma cell line Hep G2. Cohen LH; Griffioen M; Havekes L; Schouten D; van Hinsbergh V; Kempen HJ Biochem J; 1984 Aug; 222(1):35-9. PubMed ID: 6089762 [TBL] [Abstract][Full Text] [Related]
18. Effect of ketoconazole on cholesterol synthesis and on HMG-CoA reductase and LDL-receptor activities in Hep G2 cells. Kempen HJ; van Son K; Cohen LH; Griffioen M; Verboom H; Havekes L Biochem Pharmacol; 1987 Apr; 36(8):1245-9. PubMed ID: 3036162 [TBL] [Abstract][Full Text] [Related]
19. Trapidil derivatives and low density lipoprotein metabolism by human skin fibroblasts and by human hepatoma cell line Hep G2. Corsini A; Beitz J; Granata A; Fumagalli R; Mest HJ; Paoletti R Pharmacol Res; 1989; 21(5):521-31. PubMed ID: 2594609 [TBL] [Abstract][Full Text] [Related]
20. Regulation of chylomicron remnant uptake in the human hepatoma cell-line Hep G2. Role of the low-density lipoprotein receptor. Chen Q; Florén CH; Nilsson A; Infante R Biochim Biophys Acta; 1991 May; 1083(2):173-8. PubMed ID: 1645203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]